Translational Research in Ovarian Cancer
Ovarian cancer is still the most lethal gynecologic malignancy with a median five-year survival of 48%, including the less malignant and early diagnosed cases [...]
Main Authors: | Maria Flavia Di Renzo, Giorgio Valabrega |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3676 |
Similar Items
-
Patient-Derived Cancer Models
by: Maria Flavia Di Renzo, et al.
Published: (2020-12-01) -
Molecular and Translational Research on Colorectal Cancer
by: Alessandro Passardi, et al.
Published: (2020-06-01) -
Importance of Translational Research for Targeting Fibroblast Growth Factor Receptor Signaling in Cancer
by: Klaus Holzmann, et al.
Published: (2019-10-01) -
Ovarian Cancer Screening: Lessons about Effectiveness
by: Edward J. Pavlik
Published: (2017-12-01) -
The Tumor Microenvironment of High Grade Serous Ovarian Cancer
by: M. Sharon Stack, et al.
Published: (2018-12-01)